Foghorn Therapeutics Inc
Foghorn Therapeutics Inc, based in Cambridge, MA, is pioneering a new class of precision therapeutics aimed at treating serious diseases by correcting abnormal gene expression. Their innovative approach targets the chromatin regulatory system, which plays a crucial role in gene expression and is implicated in over half of all cancers and many other diseases.
The company is committed to leveraging its unique insights into this fundamental biological system to develop therapies that could transform the lives of patients across a wide spectrum of diseases. With a leadership team experienced in discovering, developing, and commercializing new therapies, Foghorn Therapeutics is positioned at the forefront of medical innovation.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
